112 related articles for article (PubMed ID: 31637684)
1. Prescription Opioid Misuse Index in sickle cell patients: A brief questionnaire to assess at-risk for opioid abuse.
Smith WR; McClish DK; Roberts JD; Kandalaft O; Dahman B; Knisely J; Levenson J; Roseff S; Aisiku IP
J Opioid Manag; 2019; 15(4):323-331. PubMed ID: 31637684
[TBL] [Abstract][Full Text] [Related]
2. Transcultural validation of a French-European version of the Prescription Opioid Misuse Index Scale (POMI-5F).
Delage N; Cantagrel N; Delorme J; Pereira B; Dualé C; Bertin C; Chenaf C; Kerckhove N; Laporte C; Picard P; Roussin A; Authier N
Can J Anaesth; 2022 Aug; 69(8):1042-1052. PubMed ID: 35229249
[TBL] [Abstract][Full Text] [Related]
3. A single-center, retrospective analysis evaluating the utilization of the opioid risk tool in opioid-treated cancer patients.
Ma JD; Horton JM; Hwang M; Atayee RS; Roeland EJ
J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):4-9. PubMed ID: 24417217
[TBL] [Abstract][Full Text] [Related]
4. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse.
Knisely JS; Wunsch MJ; Cropsey KL; Campbell ED
J Subst Abuse Treat; 2008 Dec; 35(4):380-6. PubMed ID: 18657935
[TBL] [Abstract][Full Text] [Related]
5. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
6. Clinical and socio-demographic determinants of pentazocine misuse among patients with sickle cell disease, Benin City, Nigeria: a case-control study.
Adewoyin A; Adeyemi O; Davies N; Ojo M
Pan Afr Med J; 2019; 34():88. PubMed ID: 31934231
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Detection of Prescription Opioid Misuse and Prescription Opioid Use Disorder Among Emergency Department Patients 50 Years of Age and Older: Performance of the Prescription Drug Use Questionnaire, Patient Version.
Beaudoin FL; Merchant RC; Clark MA
Am J Geriatr Psychiatry; 2016 Aug; 24(8):627-636. PubMed ID: 27426210
[TBL] [Abstract][Full Text] [Related]
8. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
Jamison RN; Ross EL; Michna E; Chen LQ; Holcomb C; Wasan AD
Pain; 2010 Sep; 150(3):390-400. PubMed ID: 20334973
[TBL] [Abstract][Full Text] [Related]
9. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
[TBL] [Abstract][Full Text] [Related]
10. Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
Shukla N; Barner JC; Lawson KA; Rascati KL
J Opioid Manag; 2021; 17(4):301-310. PubMed ID: 34533824
[TBL] [Abstract][Full Text] [Related]
11. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
Cicero TJ; Ellis MS
JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
[TBL] [Abstract][Full Text] [Related]
12. Attitudes Toward Opioids and Risk of Misuse/Abuse in Patients with Chronic Noncancer Pain Receiving Long-term Opioid Therapy.
Vargas-Schaffer G; Cogan J
Pain Med; 2018 Feb; 19(2):319-327. PubMed ID: 28340165
[TBL] [Abstract][Full Text] [Related]
13. Daily home opioid use in adults with sickle cell disease: The PiSCES project.
Smith WR; McClish DK; Dahman BA; Levenson JL; Aisiku IP; de A Citero V; Bovbjerg VE; Roberts JD; Penberthy LT; Roseff SD
J Opioid Manag; 2015; 11(3):243-53. PubMed ID: 25985809
[TBL] [Abstract][Full Text] [Related]
14. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
[TBL] [Abstract][Full Text] [Related]
15. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
[TBL] [Abstract][Full Text] [Related]
16. Rates of Opioid Misuse Amongst Patients Receiving Pain Management for Sickle Cell Disease in An Urban Setting.
Ahmed N; Okany N; Singh D; Rungkitwattanakul D; Weaver SB
J Pharm Pract; 2024 Feb; 37(1):104-109. PubMed ID: 36120980
[No Abstract] [Full Text] [Related]
17. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
[TBL] [Abstract][Full Text] [Related]
18. The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain.
Setnik B; Roland CL; Barsdorf AI; Brooks A; Coyne KS
Curr Med Res Opin; 2017 Jun; 33(6):1067-1076. PubMed ID: 28277862
[TBL] [Abstract][Full Text] [Related]
19. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
[TBL] [Abstract][Full Text] [Related]
20. Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury.
Brown R; Deyo B; Riley C; Quanbeck A; Glass JE; Turpin R; Hetzel S; Nicholas C; Cruz M; Agarwal S
Addict Sci Clin Pract; 2017 Dec; 12(1):28. PubMed ID: 29198186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
